A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9–12 month old healthy infants

Measles is a major cause of childhood mortality and one-third of the world's Measles deaths occur in India. Rubella causes lifelong birth defects (Congenital Rubella Syndrome). Although neither condition has a cure, the MR vaccination can successfully prevent both diseases. The safety of Biolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Thuluva, Subhash, Gunneri, SubbaReddy, Turaga, Kishore, Mogulla, Rammohan Reddy, Yerroju, Vijay, Peta, Kalyankumar, Suneetha, Pothakamuri Venkata, Matur, Ramesh V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696430/
http://dx.doi.org/10.1016/j.conctc.2023.101232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696430/
http://dx.doi.org/10.1016/j.conctc.2023.101232

Ejemplares similares